TBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
TrueBlue Inc (TBI) is not a strong buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock shows bearish technical indicators, weak financial performance, and lacks positive catalysts or strong trading signals. Holding off on investment is recommended until there are clearer signs of recovery or growth.
The stock is in a bearish trend with the MACD histogram at -0.0768 (below 0 and negatively expanding), RSI_6 at 19.872 (oversold), and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 4.692, and resistance levels are at 5.151 and 5.609. The stock is trading near its support level, but the overall trend remains negative.
The only positive indicator is the oversold RSI, which may suggest a potential short-term bounce. However, this is not sufficient for a long-term investment decision.
Weak financial performance in Q3 2025, with a 74.91% YoY drop in net income and a 76.92% YoY drop in EPS.
Bearish technical indicators and lack of upward momentum.
No recent news or significant insider/hedge fund activity to suggest a positive catalyst.
Stock trend analysis predicts a 70% chance of a -1.22% decline in the next day and limited upside in the next week or month.
In Q3 2025, revenue increased by 12.79% YoY to $431.27M, but net income dropped significantly by 74.91% YoY to -$1.92M. EPS fell by 76.92% YoY to -0.06, and gross margin declined by 12.74% to 21.24%. The financials indicate revenue growth but severe profitability challenges.
No recent analyst ratings or price target changes are available for TBI. Wall Street sentiment is neutral, with no strong pros or cons noted.
